W
Wolfgang Koenig
Researcher at Technische Universität München
Publications - 130
Citations - 14704
Wolfgang Koenig is an academic researcher from Technische Universität München. The author has contributed to research in topics: Population & Coronary artery disease. The author has an hindex of 37, co-authored 130 publications receiving 10052 citations. Previous affiliations of Wolfgang Koenig include University of Ulm & McGill University.
Papers
More filters
Journal ArticleDOI
Altered relation of the renin-aldosterone system and vasoactive peptides in type 2 diabetes: The KORA F4 study
Cornelia Then,Marietta Rottenkolber,Andreas Lechner,Christa Meisinger,Margit Heier,Wolfgang Koenig,Wolfgang Koenig,Annette Peters,Wolfgang Rathmann,Martin Bidlingmaier,Martin Reincke,Jochen Seissler +11 more
TL;DR: Plasma renin and aldosterone are not independent biomarkers for early atherosclerotic damages of the carotid arteries in the general community and in subjects with type 2 diabetes.
Journal ArticleDOI
Bioprofiles and mechanistic pathways associated with Cheyne-Stokes respiration: insights from the SERVE-HF trial
João Pedro Ferreira,Kevin Duarte,Holger Woehrle,Martin R. Cowie,Christiane E. Angermann,Marie Pia d'Ortho,Erland Erdmann,Patrick Levy,Anita K. Simonds,Virend K. Somers,Helmut Teschler,Karl Wegscheider,Emmanuel Bresso,Marie Dominique-Devignes,Patrick Rossignol,Wolfgang Koenig,Faiez Zannad +16 more
TL;DR: Signalling, metabolic, haemostatic and immunologic pathways underlie the expression of these biomarkers that may represent underlying mechanistic pathways associated with patterns of CSR in patients with heart failure and reduced ejection fraction.
Journal ArticleDOI
Differential Prognostic Value of Galectin-3 According to Carbohydrate Antigen 125 Levels in Transcatheter Aortic Valve Implantation.
Tobias Rheude,Costanza Pellegrini,Julio Núñez,Michael Joner,Teresa Trenkwalder,N. Patrick Mayr,Stefan Holdenrieder,Vicent Bodí,Wolfgang Koenig,Albert M. Kasel,Heribert Schunkert,Adnan Kastrati,Christian Hengstenberg,Oliver Husser +13 more
TL;DR: In patients undergoing TAVI, Gal-3 predicted adverse clinical outcomes only when CA125 was elevated, and a differential prognostic effect ofGal-3 was found across CA125 status.
Journal ArticleDOI
Immune cell-based cardiovascular risk assessment: spotlight on the neutrophil-lymphocyte ratio.
Hendrik B. Sager,Wolfgang Koenig +1 more
Journal ArticleDOI
Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT.
Marie-Pierre Dubé,Marc-André Legault,Audrey Lemaçon,Louis-Philippe Lemieux Perreault,René Fouodjio,David D. Waters,Simon Kouz,Fausto J. Pinto,Aldo P. Maggioni,Rafael Diaz,Colin Berry,Wolfgang Koenig,Jose Lopez-Sendon,Habib Gamra,Ghassan S. Kiwan,Géraldine Asselin,Sylvie Provost,Amina Barhdadi,Maxine Sun,Mariève Cossette,Lucie Blondeau,Ian Mongrain,Anick Dubois,David Rhainds,Nadia Bouabdallaoui,Michelle Samuel,Simon de Denus,Philippe L. L’Allier,Marie-Claude Guertin,François Roubille,Jean-Claude Tardif +30 more
TL;DR: The randomized, placebo-controlled COLCOT (Colchicine Cardiovascular Outcomes Trial) as discussed by the authors has shown the benefits of colchica 05 mg daily to lower the rate of ischemic cardiovascular event.